ictus - Nursing Case Study

Pathophysiology

• Primary mechanism: Ictus, or stroke, primarily results from the interruption of blood flow to the brain, often due to a thrombus or embolus, leading to ischemia. This deprivation of oxygen and nutrients causes neuronal cell death within minutes, impairing brain function.

• Secondary mechanism: In hemorrhagic stroke, a blood vessel rupture leads to bleeding in or around the brain, increasing intracranial pressure and causing further neuronal injury through mechanical compression and toxic blood metabolites.

• Key complication: Both ischemic and hemorrhagic strokes can result in significant neurological deficits, such as paralysis or aphasia, due to the affected brain tissue's role in motor, sensory, or language functions, requiring immediate medical intervention to minimize long-term disability.

Patient Profile

Demographics:

65-year-old male, retired construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia

• Current medications: Lisinopril, Metformin, Atorvastatin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Sudden weakness on the right side of the body

• Key symptoms: Slurred speech, difficulty walking, dizziness, headache

• Vital signs: Blood pressure 180/100 mmHg, heart rate 98 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F, oxygen saturation 93% on room air

Section 1

As the initial assessment continues, the medical team takes swift action to evaluate the extent of the stroke and determine the appropriate treatment strategy. A CT scan of the head is performed immediately to differentiate between ischemic and hemorrhagic stroke. The imaging reveals an ischemic stroke in the left middle cerebral artery territory, explaining the patient's right-sided weakness and language difficulties. This finding necessitates the prompt initiation of thrombolytic therapy to restore cerebral blood flow and minimize further neurological damage.

Concurrently, the laboratory results return, showing an elevated blood glucose level of 250 mg/dL and an LDL cholesterol level of 160 mg/dL, indicating suboptimal control of his Type 2 Diabetes and Hyperlipidemia. These factors are crucial as they contribute to the patient's increased risk of vascular events. The patient's elevated blood pressure of 180/100 mmHg remains a concern, necessitating careful management to avoid exacerbating the stroke.

As the medical team administers tissue plasminogen activator (tPA), the patient's response is closely monitored. Within the first hour, there is a slight improvement in his speech clarity and a reduction in the severity of his right-sided weakness. However, the team remains vigilant for potential complications, such as hemorrhagic transformation, which could occur as a result of thrombolytic therapy. Continuous monitoring of neurological status, vital signs, and any new symptoms is essential to promptly identify and address any adverse developments, guiding the next steps in the patient's journey toward recovery.

Section 2

As the medical team continues to monitor the patient closely, a new complication arises approximately three hours after the administration of thrombolytic therapy. The patient begins to exhibit a sudden decrease in consciousness, marked by a Glasgow Coma Scale (GCS) score drop from 14 to 11. His speech becomes more slurred, and there is a noticeable increase in right-sided weakness. Concerned about the potential for hemorrhagic transformation, the team quickly orders an urgent repeat CT scan of the head to assess for any bleeding complications.

The repeat CT scan reveals the presence of a small, localized hemorrhage in the area initially affected by ischemia. This finding necessitates immediate cessation of the thrombolytic therapy and prompts the team to initiate supportive measures to stabilize the patient. Blood pressure management becomes a critical focus, with antihypertensive medications being adjusted to maintain a target systolic blood pressure of less than 140 mmHg to prevent further bleeding. The patient is closely monitored in the intensive care unit, with frequent neurological assessments to detect any further deterioration.

This development requires the healthcare team to reassess the patient's treatment plan, incorporating strategies for managing both ischemic and hemorrhagic components of the stroke. The focus shifts to balancing the risk of further ischemic damage against the potential for additional bleeding. Meanwhile, the elevated blood glucose and LDL cholesterol levels are addressed by adjusting the patient's diabetes and lipid-lowering medications to reduce future vascular risks. The interdisciplinary team, including neurologists, cardiologists, and endocrinologists, collaborates to create a comprehensive plan that prioritizes stabilization and recovery, setting the stage for the next phase of the patient's complex journey toward rehabilitation and secondary prevention.

Section 3

The interdisciplinary team continues to monitor the patient closely in the intensive care unit. Over the next 24 hours, a significant change in the patient's status is noted. Despite the cessation of thrombolytic therapy and adjustments in blood pressure management, the patient exhibits signs of further neurological decline. The Glasgow Coma Scale (GCS) score, which had stabilized at 11, now drops to 9, indicating a decrease in his level of consciousness. His pupils are unequal and sluggishly reactive to light, with the right pupil larger than the left. This raises concerns about increasing intracranial pressure or expanding hemorrhage.

In response to these alarming signs, a new CT scan of the head is urgently performed, revealing an increase in the size of the intracerebral hemorrhage, now with midline shift and evidence of mass effect. The patient's vital signs show a subtle yet concerning trend: a rise in systolic blood pressure to 155 mmHg despite ongoing antihypertensive therapy, bradycardia with a heart rate of 55 bpm, and a slight increase in respiratory rate to 22 breaths per minute. These clinical findings suggest the onset of Cushing's triad, a classic sign of increased intracranial pressure.

The team promptly initiates measures to manage the elevated intracranial pressure, including the administration of intravenous mannitol and hypertonic saline, as well as elevating the head of the bed to 30 degrees. Neurosurgery is consulted for further evaluation and potential surgical intervention. The patient's family is updated on the critical situation, and discussions about the risks and benefits of surgical decompression are initiated. This shift in clinical focus underscores the complexity of managing a mixed stroke presentation and highlights the need for rapid decision-making and coordinated care as the patient's condition evolves.

Section 4

As the interdisciplinary team continues to manage the patient's critical condition, they closely observe his response to the interventions aimed at reducing intracranial pressure. Over the next 12 hours, there is a mixed response to the treatment. The administration of intravenous mannitol and hypertonic saline initially results in a slight improvement in the patient's neurological status. His Glasgow Coma Scale (GCS) score increases marginally to 10, suggesting some benefit from the osmotic therapy. However, this improvement is short-lived. Repeat neurological assessments reveal a decline, as the GCS score once again drops to 8, indicating a further reduction in consciousness.

Further complicating the situation, new lab results reveal the development of electrolyte imbalances, likely secondary to the osmotic diuresis from mannitol. The patient exhibits hyponatremia with a sodium level of 130 mmol/L and hypokalemia with a potassium level of 3.2 mmol/L. These findings necessitate prompt correction to prevent further neurological and cardiac complications. Concurrently, the patient's blood pressure continues to trend upwards, reaching 165/90 mmHg, and his heart rate remains bradycardic at 52 bpm, reinforcing concerns about persistent elevated intracranial pressure and the potential for herniation.

In light of these developments, the team revisits the plan of care, emphasizing the need for meticulous electrolyte monitoring and adjustment, while also weighing the urgency of surgical intervention. The neurosurgical team, after reviewing the latest CT scan alongside the patient's worsening clinical status, decides to proceed with emergency decompressive craniectomy to alleviate the mass effect and prevent further neurological deterioration. This decision is communicated to the patient's family, who are informed of the potential risks and benefits, preparing them for the surgical journey ahead. The focus now shifts to preparing the patient for surgery and ensuring all necessary precautions and supportive therapies are in place to optimize his chances of recovery.

Section 5

As the patient is prepped for the emergency decompressive craniectomy, the surgical team meticulously reviews the most recent diagnostic imaging and lab results to ensure no detail is overlooked. The latest CT scan shows significant midline shift and effacement of the basal cisterns, confirming the critical need for surgical intervention. Meanwhile, a repeat serum electrolyte panel indicates persistent hyponatremia, now at 128 mmol/L, and slight improvement in potassium levels, rising to 3.4 mmol/L after initial supplementation. These values necessitate continued close monitoring and further electrolyte adjustments to stabilize the patient's condition preoperatively.

In the operating room, the anesthesiology team faces the challenge of managing the patient's cardiovascular status, given his persistent bradycardia and elevated blood pressure. As the surgery progresses, the anesthesia provider administers medications to support hemodynamic stability, ensuring cerebral perfusion is maintained without exacerbating the intracranial pressure. The surgical environment is tense, with the interdisciplinary team fully aware of the delicate balance required to support the patient's physiological needs while addressing the life-threatening neurological crisis.

Postoperatively, the patient is transferred to the intensive care unit, where his condition is closely monitored. Initial assessments show that the decompressive craniectomy has alleviated some of the intracranial pressure, as evidenced by a subtle improvement in neurological responsiveness. However, the patient's GCS remains at 8, indicating that while the surgery has been beneficial, significant challenges remain. The nursing team remains vigilant for signs of further complications, such as infection or cerebral edema, which could jeopardize recovery. This critical period calls for astute clinical reasoning, as the team evaluates the effectiveness of ongoing interventions and anticipates the need for additional supportive measures to optimize the patient's trajectory toward recovery.